Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers
Smith+Nephew (LSE:SN, NYSE:SNN) has announced an exclusive digital and advanced analytics collaboration with Healthcare Outcomes Performance Company (HOPCo) to enhance solutions for Ambulatory Surgery Center (ASC) customers, physicians, and patients. The partnership integrates HOPCo's AI-powered myrecovery platform and Vitals platform with Smith+Nephew's CORI Surgical System.
This collaboration aims to provide comprehensive technology for all musculoskeletal procedures in ASCs, offering patient engagement tools, remote care management, and critical quality outcome metrics. The integration will enhance analytics for personalized surgical planning, intra-operative decision-making, and patient-reported outcomes tracking, potentially improving patient outcomes and reducing costs in value-based care settings.
Smith+Nephew (LSE:SN, NYSE:SNN) ha annunciato una collaborazione esclusiva nel campo del digitale e dell'analisi avanzata con la Healthcare Outcomes Performance Company (HOPCo) per migliorare le soluzioni per i Centri di Chirurgia Ambulatoriale (ASC), medici e pazienti. La partnership integra la piattaforma myrecovery alimentata dall'AI e la piattaforma Vitals di HOPCo con il Sistema Chirurgico CORI di Smith+Nephew.
Questa collaborazione ha l'obiettivo di fornire una tecnologia completa per tutte le procedure muscoloscheletriche negli ASC, offrendo strumenti per il coinvolgimento dei pazienti, la gestione della cura a distanza e metriche chiave sui risultati di qualità. L'integrazione migliorerà le analisi per una pianificazione chirurgica personalizzata, il processo decisionale intra-operativo e il monitoraggio degli esiti riportati dai pazienti, potenzialmente migliorando i risultati per i pazienti e riducendo i costi nei contesti di assistenza basata sul valore.
Smith+Nephew (LSE:SN, NYSE:SNN) ha anunciado una colaboración exclusiva en digital y análisis avanzado con Healthcare Outcomes Performance Company (HOPCo) para mejorar las soluciones para los Centros de Cirugía Ambulatoria (ASC), médicos y pacientes. La asociación integra la plataforma myrecovery potenciada por IA y la plataforma Vitals de HOPCo con el Sistema Quirúrgico CORI de Smith+Nephew.
Este trabajo conjunto tiene como objetivo proporcionar tecnología integral para todos los procedimientos musculoesqueléticos en los ASC, ofreciendo herramientas de participación del paciente, gestión remota de cuidados y métricas clave de resultados de calidad. La integración mejorará el análisis para una planificación quirúrgica personalizada, la toma de decisiones intraoperatorias y el seguimiento de los resultados reportados por los pacientes, potencialmente mejorando los resultados de los pacientes y reduciendo costos en entornos de atención basada en valor.
Smith+Nephew (LSE:SN, NYSE:SNN)는 Healthcare Outcomes Performance Company (HOPCo)와의 독점적인 디지털 및 고급 분석 협업을 발표하여 외래 수술 센터 (ASC) 고객, 의사 및 환자를 위한 솔루션을 향상시킵니다. 이 파트너십은 HOPCo의 AI 기반 myrecovery 플랫폼과 Vitals 플랫폼을 Smith+Nephew의 CORI 외과 시스템과 통합합니다.
이 협업의 목표는 ASC의 모든 근골격계 절차를 위한 종합적인 기술을 제공하는 것으로, 환자의 참여 도구, 원격 치료 관리 및 중요한 품질 성과 지표를 제공합니다. 통합을 통해 개인화된 수술 계획, 수술 중 의사 결정 및 환자가 보고한 결과 추적을 위한 분석이 향상되어 환자 결과를 개선하고 가치 기반 치료 환경에서 비용을 절감할 수 있습니다.
Smith+Nephew (LSE:SN, NYSE:SNN) a annoncé une collaboration exclusive dans le numérique et l'analyse avancée avec la Healthcare Outcomes Performance Company (HOPCo) pour améliorer les solutions destinées aux centres de chirurgie ambulatoire (ASC), aux médecins et aux patients. Le partenariat intègre la plateforme myrecovery alimentée par l'IA et la plateforme Vitals de HOPCo avec le Système Chirurgical CORI de Smith+Nephew.
Cette collaboration vise à fournir une technologie complète pour toutes les procédures musculosquelettiques dans les ASC, offrant des outils d'engagement des patients, une gestion des soins à distance et des indicateurs clés de résultats de qualité. L'intégration améliorera l'analyse pour une planification chirurgicale personnalisée, la prise de décision intra-opératoire et le suivi des résultats rapportés par les patients, améliorant potentiellement les résultats pour les patients et réduisant les coûts dans les contextes de soins basés sur la valeur.
Smith+Nephew (LSE:SN, NYSE:SNN) hat eine exklusive digitale und fortschrittliche Analyse-Kollaboration mit der Healthcare Outcomes Performance Company (HOPCo) angekündigt, um Lösungen für ambulante chirurgische Zentren (ASC), Ärzte und Patienten zu verbessern. Die Partnerschaft integriert HOPCos KI-gestützte myrecovery-Plattform und Vitals-Plattform mit Smith+Nephews CORI Chirurgisches System.
Diese Zusammenarbeit zielt darauf ab, umfassende Technologien für alle muskuloskelettalen Eingriffe in ASCs bereitzustellen, einschließlich Werkzeuge zur Patientenbeteiligung, Fernpflege-Management und kritische Qualitätsabschlussmetriken. Die Integration wird die Analytik für personalisierte chirurgische Planung, intraoperative Entscheidungsfindung und das Tracking der patientenberichteten Ergebnisse verbessern, was potenziell die Patientenergebnisse verbessert und die Kosten in wertbasierten Versorgungskontexten senken könnte.
- Exclusive partnership with HOPCo to enhance ASC solutions
- Integration of AI-powered analytics platforms with CORI Surgical System
- Potential for improved patient outcomes and reduced costs in value-based care
- Enhanced data-driven insights for surgeons and healthcare providers
- None.
Smith+Nephew's partnership with HOPCo represents a significant step forward in the integration of AI-powered analytics and digital health solutions in the musculoskeletal (MSK) care space, particularly for Ambulatory Surgical Centers (ASCs). This collaboration has several key implications:
- Enhanced Patient Care: The integration of HOPCo's myrecovery platform with Smith+Nephew's CORI Surgical System could lead to more personalized and effective patient care. The AI-powered platform's ability to track patient outcomes, engage patients remotely and provide real-time communication tools may significantly improve the overall patient experience and outcomes.
- Data-Driven Decision Making: The combination of intraoperative data from the CORI Surgical System with HOPCo's analytics platforms could provide surgeons with unprecedented insights. This may lead to more informed decision-making during surgeries and in post-operative care, potentially improving surgical outcomes.
- Value-Based Care: HOPCo's Vitals platform, which aims to reduce costs and improve care coordination, aligns well with the industry's shift towards value-based care models. This could position Smith+Nephew favorably in a changing healthcare landscape.
- Market Differentiation: By offering these advanced digital solutions, Smith+Nephew may gain a competitive edge in the orthopedic market, particularly in the growing ASC segment.
While the partnership shows promise, investors should monitor the implementation and adoption rates of these technologies, as well as any measurable improvements in patient outcomes or cost reductions that result from this collaboration. The success of this initiative could have a positive impact on Smith+Nephew's market position and financial performance in the medium to long term.
The collaboration between Smith+Nephew and HOPCo marks a significant advancement in the integration of AI and data analytics in orthopedic care. Here are some key technological aspects to consider:
- AI-Powered Analytics: The incorporation of AI in the myrecovery platform suggests advanced capabilities in data processing and predictive analytics. This could lead to more accurate patient outcome predictions and personalized treatment plans.
- Interoperability: The planned integration of Smith+Nephew's CORI Surgical System data with HOPCo's platforms indicates a move towards greater interoperability in healthcare IT systems. This is important for creating a comprehensive, longitudinal view of patient care.
- Remote Monitoring: The inclusion of remote therapeutic monitoring (RTM) and remote care management tools aligns with the growing trend of telemedicine and remote patient care, which could expand the reach and efficiency of orthopedic services.
- Data Security: As with any healthcare IT solution handling sensitive patient data, robust security measures will be crucial. Investors should look for assurances regarding data protection and compliance with healthcare privacy regulations.
The success of this partnership will largely depend on the seamless integration of these technologies and their adoption by healthcare providers. If successful, this could set a new standard for data-driven orthopedic care and potentially open up new revenue streams for Smith+Nephew in the healthcare IT space.
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces an exclusive digital and advanced analytics collaboration with Healthcare Outcomes Performance Company (HOPCo) – the world’s largest, fully-integrated, musculoskeletal (MSK) value-based care and outcomes management company. This collaboration will focus on enhancing solutions for ASC customers, physicians, and their patients through HOPCo’s digital health and analytics platforms, myrecovery® and Vitals®
The partnership with HOPCo provides a comprehensive technology platform that encompasses all musculoskeletal procedures performed in the ASC segment. The AI-powered myrecovery platform enhances the clinical experience by utilizing patient engagement tools such as remote care management, real time communications, and remote therapeutic monitoring (RTM), while providing critical* quality outcome metrics through proprietary activity tracking technology, functional outcomes reporting, patient-reported outcomes (PROMs), and longitudinal data integration across a patient’s care journey. HOPCo’s Vitals platform provides tools, analytics, and dashboards to help Smith+Nephew customers deliver better, more efficient and coordinated care while also meeting value-based care requirements aiming to reduce cost.
"We are thrilled to partner with HOPCo and the ability to bring their innovative digital solutions to customers in the ASC across both our Orthopaedic and Sports Medicine businesses. The HOPCo solutions will allow our customers to unlock value in the ASC be it through the use of RTM, PROMs, or leveraging analytics to drive efficiencies. Their commitment to driving meaningful change in outcomes through data aligns perfectly with the strength and value of the CORI◊ Surgical System," said Craig Gaffin, President of Global Orthopaedics at Smith+Nephew. "This collaboration underscores our commitment to advancing orthopaedic surgery through innovative technology, improving patient outcomes, and transforming the future of healthcare."
Data from the CORI Surgical System’s ability to perform image-agnostic robotic-assisted knee surgeries will now be augmented with the powerful data-driven insights from HOPCo’s Vitals and AI-powered myrecovery digital solutions. The integrated digital platform will encompass some of the most advanced practice and health system analytics solutions available. Planned integration with Smith+Nephew’s intraoperative data from the CORI Surgical System through RI.INSIGHTS Data Visualization Platform will provide surgeons and healthcare providers with enhanced analytics to link personalized surgical planning, intra-operative decision-making, and PROMS tracking and optimization.
“Smith+Nephew is clearly committed to using outcomes data to enhance the value of its products and services,” said Dr. David Jacofsky, CEO and Chairman at HOPCo. “HOPCo’s myrecovery and Vitals platforms will allow Smith+Nephew to leverage unique longitudinal data to do just that, while simultaneously providing meaningful additional value to customers and improving patient outcomes.”
- ends –
Media Enquiries
Dave Snyder +1 (978) 749-1440
Smith+Nephew david.snyder@smith-nephew.com
About Smith+Nephew
Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 18,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of
For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on X, LinkedIn, Instagram or Facebook.
About HOPCo
Healthcare Outcomes Performance Company (HOPCo) is the global leader of integrated musculoskeletal value-based health outcomes management, digital analytics, practice management, and health system service line management. This includes comprehensive expertise across all MSK specialties, including orthopedics, spine, pain management, rehabilitation, neurosurgery, and neurology. HOPCo's integrated care, analytics, and facilities development platforms have proven to increase the quality of patient care while reliably reducing the total cost of MSK care across the care continuum for practices, health systems and payors alike. HOPCo's affiliated payors, practices and health systems successfully participate in highly efficient value-based contracting (bundled payments, population health programs, and other advanced risk-based arrangements) utilizing HOPCo's proprietary platforms, IT solutions, integrated analytics, advanced medical economics and standardized care pathways. Visit www.hopco.com to learn more.
Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC’s website at www. sec.gov, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.
◊ Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office.
FAQ
What is the purpose of Smith+Nephew's partnership with HOPCo?
How will the collaboration between Smith+Nephew (SNN) and HOPCo benefit ASC customers?
What platforms are being integrated in the Smith+Nephew (SNN) and HOPCo partnership?
How does the Smith+Nephew (SNN) and HOPCo collaboration aim to improve patient care?
